Agostini, Antonio
 Distribuzione geografica
Continente #
EU - Europa 87
NA - Nord America 65
AS - Asia 24
Totale 176
Nazione #
US - Stati Uniti d'America 64
IT - Italia 44
CN - Cina 14
SE - Svezia 14
IE - Irlanda 7
DE - Germania 6
GB - Regno Unito 6
FR - Francia 4
RU - Federazione Russa 4
SG - Singapore 4
HK - Hong Kong 2
IN - India 2
TW - Taiwan 2
CA - Canada 1
CH - Svizzera 1
NL - Olanda 1
Totale 176
Città #
Chandler 19
Rome 18
Ashburn 11
Milan 10
Boardman 4
Cattolica 4
Dublin 4
Marseille 4
Chions 3
Beijing 2
Guwahati 2
Hong Kong 2
London 2
Nuremberg 2
Princeton 2
Singapore 2
Verona 2
Augusta 1
Bern 1
Boston 1
Bremen 1
Chiswick 1
Fairfield 1
Hounslow 1
Houston 1
Hsinchu 1
Moscow 1
Mountain View 1
New Bedfont 1
Ottawa 1
Redmond 1
Sacramento 1
Salerno 1
St Petersburg 1
Taipei 1
Trieste 1
Washington 1
Wilmington 1
Woodbridge 1
Zhengzhou 1
Totale 116
Nome #
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 83
Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response 40
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 34
Immunogenic Cell Death: An Emerging Target in Gastrointestinal Cancers 9
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 7
KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy 7
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms 5
Totale 185
Categoria #
all - tutte 1.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.460


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202231 0 0 0 0 7 3 4 3 3 1 5 5
2022/202372 10 11 4 8 2 7 6 2 9 0 3 10
2023/202479 0 9 4 2 7 6 13 0 1 13 5 19
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 185